NCT04942301 2021-06-30
PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Unknown
Clinical Trials
7 trialsNCT02513355 2015-08-04
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Phase 4 Unknown
NCT00912392 2014-09-03
Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Phase 2 Completed
NCT01002092 2014-09-03
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Phase 2 Unknown
NCT01327235 2014-08-01
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT01410370 2013-04-24
Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 2 Unknown
NCT01531790 2013-01-16
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Completed